Aquestive Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2017 | $5.8M | $3.8M | $2.1M | $0 |
| FY2018 | $-13.0M | $-14.8M | $1.8M | $29.9M |
| FY2019 | $-60.2M | $-60.9M | $663.0K | $7.1M |
| FY2020 | $-45.5M | $-46.0M | $517.0K | $6.6M |
| FY2021 | $-33.0M | $-33.9M | $913.0K | $6.8M |
| FY2022 | $-9.8M | $-10.8M | $1.0M | $4.4M |
| FY2023 | $-6.4M | $-7.4M | $995.0K | $2.7M |
| FY2024 | $-35.8M | $-35.9M | $159.0K | $7.1M |
| FY2025 | $-52.4M | $-53.0M | $562.0K | $7.6M |